Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2026-02-03 @ 9:44 PM
Study NCT ID:
NCT01657461
Status:
COMPLETED
Last Update Posted:
2017-05-18
First Post:
2012-08-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
Sponsor:
Medtronic Neurovascular Clinical Affairs
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Ischemic Stroke | View |
Keywords: